Search results
6 mar 2024 · — New clinical trial data for bemdaneprocel, a promising stem cell-derived therapy for Parkinson’s disease, continues to show positive results 18 months after treatment, scientists reported today at an international conference in Portugal.
- Stem-cell therapy shows promise for Parkinson's disease
After decades of researching and treating Parkinson's...
- Stem-cell therapy shows promise for Parkinson's disease
23 sty 2024 · Stem cells hold promise for slowing, or even reversing, the progression of Parkinson’s. For more than a decade, researchers have worked to harness the potential of stem cells to treat Parkinson’s. In this blog, we will take a look at the research, see how far we’ve come and look to the future.
The new treatment being tested in patients with advanced Parkinson's involves embryonic stem cells transformed into dopamine-producing neurons that are surgically transplanted into the putamen, the area of the mid brain that is no longer producing dopamine.
1 sie 2022 · The goal of stem cell therapy for Parkinson’s disease is to replace destroyed brain cells with healthy, undifferentiated stem cells. These stem cells can then transform into brain...
15 paź 2020 · Herein, we provide updates on current progress in stem cell-derived DA neuron transplantation as a therapeutic alternative for PD.
11 sty 2024 · After decades of researching and treating Parkinson's disease, UCI Health neurologist Dr. Claire Henchcliffe reports promising results a first-in-human clinical trial of stem cells engineered to replace dopamine-producing neurons destroyed by the disease.
12 sty 2023 · In this Review, we discuss the rationale for dopamine cell-based therapies for PD, and the translational and clinical barriers that have been identified. Where appropriate, we briefly...
